Novo Nordisk's Ozempic (Photo: Shutterstock)

Dis­counts for weight loss drugs are es­ti­mat­ed at more than half, fu­el­ing ques­tions about price, PBMs and cov­er­age

Pop­u­lar weight loss drugs are like­ly be­ing dis­count­ed by half or more from their list prices, ac­cord­ing to a new study, a gap that’s ex­pect­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.